GlassScriptPhysician profile
James L Gardner
NPI 1194766162
$18,719.96
in general payments reported to CMS, 2019-2025
52 companies · $3,057 in 2025
The $3,057 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,611 · 2020: $2,268 · 2021: $2,713 · 2022: $2,844 · 2023: $3,266 · 2024: $2,962 · 2025: $3,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,128 · Education: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,128.23 |
| Education | $156.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,668.68 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $1,745.83 | 2019-2025 | |
| Amgen INC. | $1,741.78 | 2019-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $1,494.02 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $1,426.56 | 2019-2025 | |
| Novo Nordisk INC | $1,396.44 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $837.11 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $805.83 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $638.59 | 2019-2022 | |
| Medtronic, INC. | $532.23 | 2021-2024 | Minimed 780g, Minimed 770g, Inpen Smart Insulin Delivery System |
| Otsuka America Pharmaceutical, INC. | $517.40 | 2021-2025 | Rexulti, Nuedexta, Jynarque |
| Lundbeck LLC | $481.85 | 2021-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $458.22 | 2019-2025 | Gardasil 9, Capvaxive, M-M-R II |
| Astellas Pharma US INC | $422.02 | 2020-2025 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $371.55 | 2023-2025 | Cologuard Collection Kit |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.